Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ir-Med Inc (OP:IRME)

0.0449 +0.0025 (+5.90%)
Streaming Delayed Price Updated: 3:08 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 23,721
Open 0.0300
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0424
Today's Range 0.0300 - 0.0449
52wk Range 0.0100 - 0.8550
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
IR-MED Ltd. Announces Launch of First-in-Human Clinical Trial of Its DiaSafe(TM) Device for Diabetic Foot Ulcer (DFU) Assessment
DiaSafe™ technology for non-invasive DFU risk assessment and early intervention*The DFU treatment market is estimated to be approximately$10 billion globally1Rosh Pina,... 
Via Newsfile
Topics Artificial Intelligence
IR-MED's Key Clinical and Media Milestones
Rosh Pina, Israel--(Newsfile Corp. - October 27, 2025) - IR-Med Inc. (OTCQB: IRME), (the "Company" or "IR-Med"), a medical technology... 
Via Newsfile
Topics Artificial Intelligence

Performance

YTD
-90.6%
-90.6%
1 Month
+38.2%
+38.2%
3 Month
+156.6%
+156.6%
6 Month
-16.9%
-16.9%
1 Year
-92.1%
-92.1%

More News

Read More
IR-MED Investor Update Letter - Sept-2025
Via Newsfile
Topics Artificial Intelligence
IR-MED Reports Positive Interim Results from U.S. Clinical Study of PressureSafe(TM) for Pressure Injury Assessment Across Diverse Skin Tones
Via Newsfile
Topics Artificial Intelligence
IR-MED Awarded $500,000 Grant from the Israel Innovation Authority to Advance AI-Powered DiaSafe(TM) Device for Diabetic Foot Ulcer Assessment
Via Newsfile
Topics Artificial Intelligence
IR-Med Announces Dr. David Dalton as Advisory Board member
From IR-Med, Inc.
Via GlobeNewswire
IR-MED Names Moshe Gerber as New CEO
From IR-MED
Via Business Wire
IR-Med Announces $3.2 Million Private Placement
From IR-Med
Via Business Wire
This Company Plans to Stop Pressure Wound casualties: Introducing IR-Med (OTCQB: IRME)
Via Get News
Topics Artificial Intelligence
Following Its Recent Annual Updates: IR-Med Announces OTCQB Up-listing: “A Significant Achievement for the Company”
From IR-Med
Via Business Wire
IR-Med to Announce 2022 Goals: Anticipated POC Results, File for FDA Clearance and up Listing to the OTCQB
From IR-Med
Via Business Wire

Frequently Asked Questions

Is Ir-Med Inc publicly traded?
Yes, Ir-Med Inc is publicly traded.
What exchange does Ir-Med Inc trade on?
Ir-Med Inc trades on the OTC Traded
What is the ticker symbol for Ir-Med Inc?
The ticker symbol for Ir-Med Inc is IRME on the OTC Traded
What is the current price of Ir-Med Inc?
The current price of Ir-Med Inc is 0.0449
When was Ir-Med Inc last traded?
The last trade of Ir-Med Inc was at 11/03/25 03:08 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.